Cigna Group

CI Healthcare Healthcare Plans

Cigna Group’s revenue for fiscal 2025 (year ended December 2025) was $274.9 billion, up 11.2% from fiscal 2024. In the quarter to June 2026, revenue grew 6.68%, EPS grew 10.2%, free cash flow grew 66.9% and total debt rose 3.61%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten; insiders bought in the last twelve months.

282.53 0.81 −0.29%
Market cap
$74.7B
P/E
11.7×
Fwd P/E
11.4×
Dividend yield
2.19%
F-score
8/9
Altman Z
2.62
Beneish M
−2.47
Dividend safety
82/100
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
12.41 22.56 17.83 15.04 14.59 9.01 15.23 17.75 23.20 18.85
Piotroski F-Score
8 7 5 9 6 8 7 6 7 7
Altman Z-Score
2.62 2.43 2.21 2.33 1.93 1.83 1.66 0.70 1.50 1.21
P/S ratio
0.27 0.31 0.47 0.55 0.45 0.47 0.50 0.96 1.22 0.87
P/FCF ratio
8.75 8.64 8.90 13.52 12.86 8.21 9.11 14.45 14.06 9.72
Altman Z″-Score (non-manufacturers)
1.10 0.88 1.02 1.15 0.98 1.10 0.66 0.37 (0.52) (0.80)
Beneish M-Score
(2.47) (2.47) (2.69) (2.48) (2.40) (2.45) (1.50) (1.70) (2.64) (2.73)
P/Operating CF
11.94 14.85 62.12 47.41 18.15 17.69 27.52 371.78 88.38 40.92
Dividend Safety Score
82 — — — — — — — — —
P/B ratio
1.75 1.88 1.97 2.23 1.65 1.51 1.70 1.14 3.71 2.52
Price to Tangible BV
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.06 4.47
EV/Sales
0.35 0.41 0.59 0.69 0.61 0.62 0.71 1.76 1.27 0.92
EV/EBITDA
8.12 8.35 9.87 10.95 9.78 9.01 9.35 17.60 11.82 9.87
EV/Operating CF
10.12 9.83 9.67 14.40 14.77 9.54 11.56 22.67 13.04 9.07
EV/FCF
11.59 11.37 11.16 16.94 17.59 10.67 13.00 26.36 14.74 10.24
Quick Ratio
0.72 0.65 0.65 0.69 0.68 0.77 0.61 0.62 0.38 0.39
Current Ratio
0.72 0.65 0.65 0.69 0.68 0.77 0.61 0.62 0.38 0.39
Net Debt/EBITDA
1.99 2.00 2.00 2.21 2.63 2.08 2.80 7.96 0.55 0.50
Debt/Assets
19.92% 20.51% 20.25% 21.61% 21.74% 21.18% 24.01% 27.72% 8.81% 8.48%
Debt/Equity
0.75 0.78 0.67 0.70 0.71 0.65 0.83 1.04 0.40 0.37
Asset Turnover
1.75 1.60 1.32 1.21 1.12 1.03 0.99 0.45 0.69 0.68
Operating CF/Net income
1.61 3.02 2.29 1.29 1.34 1.22 1.86 1.43 1.83 2.16
Capex/Depreciation
(0.44) (0.51) (0.52) (0.44) (0.39) (0.39) (0.29) (0.76) (0.83) (0.76)
Interest Coverage
6.53 6.56 5.90 6.88 6.57 5.67 4.80 8.35 15.64 11.11
ROE
14.33% 7.85% 11.36% 14.60% 11.02% 17.68% 11.82% 9.63% 16.31% 14.49%
ROA
3.80% 2.23% 3.48% 4.49% 3.46% 5.44% 3.30% 2.45% 3.69% 3.21%
ROIC
8.76% 8.96% 7.69% 7.56% 6.55% 6.97% 6.46% 3.26% 15.23% 12.39%
Return on Tangible Assets
(49.05%) (21.79%) (41.19%) (75.39%) (64.43%) (199.29%) (60.23%) (35.17%) (12.37%) (10.04%)
Average Days of Receivables
43.64 42.25 42.16 45.77 42.02 39.57 37.59 119.89 77.86 87.54
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
5.32% 6.01% 7.59% 7.30% 7.48% 8.77% 9.15% 24.53% 23.99% 24.57%
Intangible Assets out of Total Assets
0.47 0.47 0.49 0.54 0.52 0.51 0.52 0.55 0.11 0.10
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Graham Net Nets
(1.03) (1.01) (0.84) (0.71) (1.06) (1.02) (1.17) (1.97) (0.71) (0.95)
Graham Number
279.90 201.30 248.13 263.53 222.23 267.77 190.92 200.13 103.61 93.32
Earnings Yield
8.06% 4.43% 5.61% 6.65% 6.85% 11.10% 6.57% 5.63% 4.31% 5.31%
Free Cash Flow Yield
11.43% 11.57% 11.24% 7.40% 7.78% 12.18% 10.97% 6.92% 7.11% 10.29%
Revenue per Share
1,030.58 881.65 664.41 583.17 515.05 439.48 408.51 197.24 166.63 156.01
Operating CF per Share
35.99 36.97 40.20 27.96 21.28 28.36 25.23 15.28 16.29 15.77
Capex per Share
(4.54) (5.02) (5.35) (4.18) (3.41) (3.00) (2.79) (2.14) (1.88) (1.81)
Free Cash Flow per Share
31.45 31.96 34.84 23.78 17.86 25.36 22.44 13.14 14.41 13.96
Cash per Share
28.78 26.94 26.62 19.14 15.03 27.90 12.29 15.63 11.85 12.47
Shareholders Equity per Share
156.98 147.14 157.35 144.37 139.45 137.89 120.62 166.37 54.65 53.76
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
156.98 147.14 157.35 144.37 139.45 137.89 120.62 166.37 54.65 53.76
Free Cash Flow
8,389.00 8,957.00 10,240.00 7,361.00 6,037.00 9,256.00 8,435.00 3,242.00 3,615.00 3,565.00
Working Capital
(15,795.00) (19,414.00) (16,233.00) (12,667.00) (12,027.00) (8,449.00) (12,891.00) (12,060.00) (19,649.00) (20,139.00)
Capital Expenditures
(1,212.00) (1,406.00) (1,573.00) (1,295.00) (1,154.00) (1,094.00) (1,050.00) (528.00) (471.00) (461.00)
Net Current Asset Value
(75,498.00) (78,483.00) (76,138.00) (70,639.00) (82,637.00) (77,550.00) (89,995.00) (92,356.00) (36,158.00) (32,893.00)
EV/EBIT
10.57 10.81 13.38 14.76 13.37 12.11 13.58 20.55 13.52 11.82
Capex to Sales
0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Price to Operating Income
7.98 8.22 10.68 11.78 9.77 9.32 9.52 11.26 12.89 11.22
Other line items
Depreciation/Fixed assets
0.76 0.76 0.82 0.78 0.79 0.67 0.83 0.15 0.36 0.40
Cash ROIC
10.36% 11.09% 12.05% 9.01% 7.03% 9.91% 9.65% 3.71% 16.34% 16.25%
Accounts Receivable Turnover
8.94 9.66 8.64 8.46 9.30 9.66 9.66 3.91 4.53 3.97
Accounts Payable Turnover
0.87 1.17 1.36 1.38 1.65 1.90 2.01 1.53 1.12 1.02
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Days of Payables
435.59 356.60 285.35 281.77 238.85 210.06 184.09 199.79 303.68 362.06
Days of Inventory on Hand
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Receivables
30,738.00 25,581.00 22,595.50 21,337.50 18,716.00 16,603.50 15,898.00 12,449.00 9,236.50 10,031.00
Average Payables
39,375.50 33,063.50 26,606.50 23,404.50 20,394.50 17,184.50 15,306.00 18,043.50 22,582.00 23,837.50
Average Assets
156,900.00 154,321.00 148,323.00 149,387.00 155,170.00 155,612.50 154,500.00 107,492.50 60,559.50 58,224.00
Average Common Equity
41,558.50 43,743.50 45,466.00 45,909.00 48,729.00 47,836.00 43,189.50 27,373.00 13,719.00 12,885.50

Fold the line items

Columns are period end dates